Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans & Pricing
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
DRMA
Stock Latest News
Company Announcements
Dermata Therapeutics Reports Positive Phase 3 Trial Results
6d ago
8K
DRMA
Premium
The Fly
Dermata Therapeutics Inc trading halted, news pending
19d ago
DRMA
Premium
Company Announcements
Dermata Therapeutics Announces Reverse Stock Split
21d ago
8K
DRMA
Premium
Company Announcements
Dermata Therapeutics Holds Annual Stockholders Meeting
1M ago
8K
DRMA
Premium
The Fly
Dermata Therapeutics receives notice of grant of Australian patent
1M ago
DRMA
Premium
Company Announcements
Dermata Faces Nasdaq Delisting Risk, Plans Stock Split
1M ago
8K
DRMA
Premium
Company Announcements
Dermata Therapeutics Begins Manufacturing for STAR-2 Trial
3M ago
8K
DRMA
Premium
The Fly
Dermata Therapeutics price target lowered to $3 from $6 at Maxim
3M ago
DRMA
Premium
Company Announcements
Dermata Faces Nasdaq Delisting Risk Over Bid Price
3M ago
8K
DRMA
Premium
Company Announcements
Dermata Reports Positive Phase 3 Trial Results
3M ago
8K
DRMA
Premium
The Fly
Dermata Therapeutics reports Q1 EPS (45c) vs. ($7.06) last year
3M ago
DRMA
Premium
The Fly
Dermata Therapeutics sees cash runway into 1Q26
3M ago
DRMA
Premium
Ratings
Optimistic Buy Rating for Dermata Therapeutics Driven by Promising Phase 3 Trial Results and Strong Financial Position
4M ago
DRMA
Premium
The Fly
Dermata Therapeutics files to sell 10.01M shares of common stock for holders
4M ago
DRMA
Premium
The Fly
Dermata’s XYNGARI trial hits statistically significant difference at 4 weeks
4M ago
DRMA
Premium
Ratings
Buy Rating for Dermata Therapeutics: Promising Phase 3 Results and Strategic Advantages
5M ago
DRMA
Premium
The Fly
Dermata Therapeutics’ xyngari in acne meets all primary Phase 3 endpoints
5M ago
DRMA
Premium
The Fly
Dermata Therapeutics announces last patient visit in Phase 3 acne trial
6M ago
DRMA
Premium
The Fly
Dermata Therapeutics receives notice of acceptance for Australian patent
6M ago
DRMA
Premium
The Fly
APO accepts Dermata’s patent application for DMT410 program for hyperhidrosis
6M ago
DRMA
Premium
The Fly
Dermata Therapeutics files to sell 1.94M shares of common stock for holders
7M ago
DRMA
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
7M ago
INM
IPA
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >
You need to enable JavaScript to run this app.
